Skip Ribbon Commands
Skip to main content
Menu

Ovarian Hyperstimulation Syndrome (OHSS)

Ovarian Hyperstimulation Syndrome (OHSS) - What it is

The medications (gonadotrophins) used to stimulate your ovaries during in-vitro fertilisation (IVF) or associated procedures for fertility treatment are designed to ensure that a reasonable number of eggs are obtained to maximise your chances of pregnancy. OHSS happens when too many ovarian follicles have developed in response to the usual dosage of medication. It is a result of the hormones produced by the ovaries in response to the usual dosage of medication. It is a result of the hormones produced by the ovaries in response to the drugs given.

OHSS is usually mild and causes no more than a slight lower abdominal discomfort in most cases.

Although uncommon, it warrants medical attention as it can be potentially life threatening, if left untreated in severe cases.

When detected early and managed appropriately, the condition can be controlled.

Occurrence Of OHSS

Some 6% to 8% of patients undergoing IVF treatment will experience mild forms of OHSS. The severe form will affect less than 1% of patients.

Ovarian Hyperstimulation Syndrome (OHSS) - Causes and Risk Factors

Ovarian Hyperstimulation Syndrome (OHSS) - Diagnosis

Ovarian Hyperstimulation Syndrome (OHSS) - Preparing for surgery

Ovarian Hyperstimulation Syndrome (OHSS) - Post-surgery care

The information provided is not intended as medical advice. Terms of use. Information provided by SingHealth

TOP
Discover articles,videos, and guides afrom Singhealth's resources across the web. These information are collated, making healthy living much easier for everyone.